Charlotte Smith Hand, MD
Dermatology · Augusta
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Dermatology Specialists of Augusta, Inc · 6 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hand’s office at (706) 863-0500 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$236,978
Medicare paid this office $236,978 for 937 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 453 | $31,229 | $57 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 80 | $30,703 | $313 |
| Return visit (30+ min) | 275 | $28,094 | $78 |
| Biopsy of related skin growth, first growth | 291 | $20,982 | $59 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 54 | $17,586 | $293 |
See all 24 services
| Short return visit (20+ min) | 453 | $31,229 | $57 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 80 | $30,703 | $313 |
| Return visit (30+ min) | 275 | $28,094 | $78 |
| Biopsy of related skin growth, first growth | 291 | $20,982 | $59 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 54 | $17,586 | $293 |
| Destruction of skin growth, 1-14 growths | 203 | $17,250 | $73 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 100 | $11,820 | $94 |
| Destruction of precancer skin growth, 1 growth | 271 | $10,937 | $33 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 25 | $9,086 | $349 |
| New patient visit (30+ min) | 68 | $5,370 | $79 |
| New patient visit (45+ min) | 52 | $5,338 | $103 |
| Biopsy of related skin growth, each additional growth | 99 | $5,001 | $35 |
| Short return visit | 115 | $4,350 | $34 |
| Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 27 | $3,452 | $123 |
| Complicated repair of wound of scalp, arms, or legs, 1.1-2.5 cm | 11 | $3,009 | $274 |
| Destruction of precancer skin growth, 2-14 growths | 164 | $2,566 | $5 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 15 | $2,267 | $126 |
| Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 19 | $2,069 | $109 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 15 | $1,729 | $108 |
| New patient visit (15+ min) | 38 | $1,300 | $34 |
| Biopsy of ear | 27 | $1,090 | $40 |
| Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | 12 | $863 | $66 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less | 11 | $734 | $67 |
| Injection into skin growth, 1-7 growths | 11 | $400 | $31 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 216 | More than 98% of doctors who do this |
| Removal of skin lesions | 679 | More than 90% of doctors who do this |
| Removal or shaving of skin growth | 31 | More than 75% of doctors who do this |
| Skin biopsy | 363 | More than 93% of doctors who do this |
Who their Medicare patients are
937 Original Medicare patients in 2024. Average age 74 · Under 65 3% · 85 and older 8% · Women 53% · Also on Medicaid 2% · Health risk score 0.96. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 72% · Diabetes 27% · Coronary heart disease 24% · Chronic kidney disease 23% · Depression 19% · Atrial fibrillation 14% · Heart failure 12% · Cancer 12% · COPD 12% · Stroke 7% · Dementia 4%.
The office billed $706,054, Medicare allowed $332,460 and paid $236,978; for 3,492 services of 76 kinds; $87 of it was for drugs given in the office and $236,891 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 937 | 3,492 | 74 | 0.96 | $706,054 | $236,978 |
| 2023 | 761 | 3,309 | 74 | 0.90 | $646,171 | $209,877 |
| 2022 | 151 | 466 | 73 | 1.27 | $86,011 | $30,971 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Short return visit (20+ min) | 425 | $28,971 | $55 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 62 | $22,503 | $300 |
| Return visit (30+ min) | 180 | $19,421 | $87 |
| Destruction of skin growth, 1-14 growths | 221 | $18,720 | $72 |
| Biopsy of related skin growth, first growth | 236 | $17,471 | $59 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 39 | $17,194 | $344 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 42 | $13,830 | $282 |
| Destruction of precancer skin growth, 1 growth | 240 | $9,345 | $30 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 68 | $7,758 | $91 |
| Short return visit | 140 | $5,743 | $35 |
| New patient visit (30+ min) | 73 | $4,402 | $60 |
| Biopsy of related skin growth, each additional growth | 72 | $4,097 | $36 |
| Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 31 | $4,017 | $106 |
| New patient visit (45+ min) | 35 | $3,599 | $103 |
| Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 24 | $2,960 | $99 |
| Destruction of precancer skin growth, 2-14 growths | 157 | $2,626 | $4 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 18 | $2,228 | $111 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 13 | $1,641 | $117 |
| New patient visit (15+ min) | 39 | $1,483 | $38 |
| Punch biopsy, first skin growth | 11 | $1,006 | $91 |
| Biopsy of ear | 18 | $849 | $45 |
| Removal of skin tag, 1-15 skin tags | 20 | $795 | $40 |
| Injection into skin growth, 1-7 growths | 17 | $607 | $28 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $35 | None |
2022: 11 services
| Biopsy of related skin growth, first growth | 48 | $3,745 | $69 |
| Short return visit (20+ min) | 43 | $3,184 | $66 |
| New patient visit (45+ min) | 23 | $2,724 | $118 |
| New patient visit (30+ min) | 30 | $2,262 | $75 |
| Return visit (30+ min) | 18 | $1,858 | $88 |
| Destruction of skin growth, 1-14 growths | 21 | $1,749 | $76 |
| Destruction of precancer skin growth, 1 growth | 32 | $1,237 | $34 |
| Short return visit | 22 | $1,058 | $41 |
| Biopsy of related skin growth, each additional growth | 19 | $862 | $37 |
| New patient visit (15+ min) | 12 | $649 | $54 |
| Destruction of precancer skin growth, 2-14 growths | 22 | $417 | $5 |
Drugs they prescribed that Part D paid
$1,263,978
Pharmacies billed $1,263,978 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,478 generic and 181 brand-name prescriptions · $1,263,978 in drug cost · 168 antibiotic prescriptions to 98 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 22 | $230,995 | $10,500 |
| Otezla | 43 | $224,059 | $5,211 |
| Dupixent | 38 | $153,783 | $4,047 |
| Clobetasol Propionate | 342 | $15,054 | $44 |
| Tacrolimus | 35 | $3,955 | $113 |
See all 32 drugs
| Humira(Cf) | 22 | $230,995 | $10,500 |
| Otezla | 43 | $224,059 | $5,211 |
| Dupixent | 38 | $153,783 | $4,047 |
| Clobetasol Propionate | 342 | $15,054 | $44 |
| Tacrolimus | 35 | $3,955 | $113 |
| Calcipotriene | 22 | $2,471 | $112 |
| Doxycycline Hyclate | 115 | $2,265 | $20 |
| Fluorouracil | 32 | $1,819 | $57 |
| Tretinoin | 23 | $1,805 | $78 |
| Clindamycin Phosphate | 31 | $1,377 | $44 |
| Fluocinolone Acetonide | 32 | $1,259 | $39 |
| Ketoconazole | 91 | $1,046 | $11 |
| Ammonium Lactate | 68 | $1,033 | $15 |
| Triamcinolone Acetonide | 72 | $999 | $14 |
| Glycopyrrolate | 16 | $993 | $62 |
| Hydrocortisone | 60 | $972 | $16 |
| Halobetasol Propionate | 19 | $856 | $45 |
| Metronidazole | 11 | $730 | $66 |
| Betamethasone Dipropionate | 12 | $696 | $58 |
| Spironolactone | 50 | $541 | $11 |
| Mometasone Furoate | 27 | $482 | $18 |
| Minocycline | 20 | $456 | $23 |
| Terbinafine | 95 | $378 | $4 |
| Ciclopirox | 15 | $257 | $17 |
| Fluconazole | 21 | $251 | $12 |
| Mupirocin | 34 | $240 | $7 |
| Minoxidil | 59 | $223 | $4 |
| Valacyclovir | 11 | $214 | $19 |
| Prednisone | 20 | $181 | $9 |
| Sulfamethoxazole-Trimethoprim | 35 | $181 | $5 |
| Doxepin | 11 | $119 | $11 |
| Hydroxyzine | 11 | $60 | $5 |
Year by year
| 2024 | 1,659 | 523 | None | 11% | $1,263,978 |
| 2023 | 1,244 | 429 | None | 10% | $614,477 |
| 2022 | 309 | 109 | 0% (0) | 17% | $254,239 |
| 2021 | 277 | 93 | None | 28% | $357,976 |
| 2020 | 520 | 139 | None | 28% | $614,411 |
| 2019 | 264 | 118 | None | None | $128,404 |
| 2018 | 15 | None | None | None | $582 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Dupixent | 44 | $169,452 | $3,851 |
| Humira(Cf) | 14 | $139,424 | $9,959 |
| Otezla | 18 | $104,616 | $5,812 |
| Clobetasol Propionate | 217 | $12,507 | $58 |
| Calcipotriene | 30 | $4,869 | $162 |
| Fluorouracil | 31 | $3,495 | $113 |
| Doxycycline Hyclate | 110 | $2,998 | $27 |
| Fluocinolone Acetonide | 27 | $2,611 | $97 |
| Halobetasol Propionate | 27 | $1,732 | $64 |
| Ketoconazole | 94 | $1,712 | $18 |
| Hydrocortisone | 74 | $1,003 | $14 |
| Clindamycin Phosphate | 14 | $868 | $62 |
| Tretinoin | 11 | $804 | $73 |
| Ammonium Lactate | 39 | $546 | $14 |
| Minocycline | 19 | $463 | $24 |
| Triamcinolone Acetonide | 47 | $448 | $10 |
| Mometasone Furoate | 37 | $433 | $12 |
| Sulfamethoxazole-Trimethoprim | 20 | $410 | $21 |
| Spironolactone | 28 | $395 | $14 |
| Terbinafine | 57 | $384 | $7 |
| Fluconazole | 25 | $335 | $13 |
| Valacyclovir | 14 | $329 | $23 |
| Hydroxychloroquine Sulfate | 12 | $316 | $26 |
| Doxepin | 22 | $308 | $14 |
| Mupirocin | 32 | $286 | $9 |
| Doxycycline Monohydrate | 11 | $231 | $21 |
| Hydroxyzine | 17 | $169 | $10 |
2022: 8 drugs
| Dupixent | 13 | $45,160 | $3,474 |
| Clobetasol Propionate | 53 | $3,615 | $68 |
| Calcipotriene | 15 | $2,497 | $166 |
| Doxycycline Hyclate | 17 | $610 | $36 |
| Ketoconazole | 18 | $392 | $22 |
| Hydrocortisone | 23 | $350 | $15 |
| Triamcinolone Acetonide | 14 | $134 | $10 |
| Prednisone | 11 | $117 | $11 |
2021: 8 drugs
| Otezla | 22 | $90,272 | $4,103 |
| Dupixent | 16 | $52,011 | $3,251 |
| Calcipotriene | 22 | $4,710 | $214 |
| Clobetasol Propionate | 31 | $1,596 | $51 |
| Hydroxychloroquine Sulfate | 14 | $732 | $52 |
| Hydrocortisone | 19 | $287 | $15 |
| Ketoconazole | 14 | $277 | $20 |
| Triamcinolone Acetonide | 22 | $216 | $10 |
2020: 16 drugs
| Humira | 23 | $181,844 | $7,906 |
| Otezla | 45 | $145,174 | $3,226 |
| Dupixent | 14 | $45,645 | $3,260 |
| Acitretin | 11 | $7,554 | $687 |
| Calcipotriene | 21 | $4,820 | $230 |
| Clobetasol Propionate | 50 | $3,060 | $61 |
| Hydroxychloroquine Sulfate | 32 | $2,314 | $72 |
| Doxepin | 34 | $1,588 | $47 |
| Betamethasone Dipropionate | 19 | $1,536 | $81 |
| Mycophenolate Mofetil | 11 | $1,097 | $100 |
| Ketoconazole | 36 | $933 | $26 |
| Doxycycline Hyclate | 13 | $455 | $35 |
| Hydrocortisone | 15 | $365 | $24 |
| Triamcinolone Acetonide | 29 | $308 | $11 |
| Hydroxyzine | 11 | $139 | $13 |
| Prednisone | 13 | $136 | $10 |
2019: 7 drugs
| Calcipotriene | 20 | $2,503 | $125 |
| Fluorouracil | 19 | $2,334 | $123 |
| Clobetasol Propionate | 20 | $1,949 | $97 |
| Ketoconazole | 21 | $477 | $23 |
| Hydrocortisone | 12 | $216 | $18 |
| Doxycycline Hyclate | 11 | $207 | $19 |
| Triamcinolone Acetonide | 14 | $73 | $5 |
Money from drug and device companies
$3,769 in 2025
| 2025 | 17 | 101 | $1,950 | $3,769 |
| 2024 | 17 | 144 | None | $2,410 |
| 2023 | 15 | 78 | None | $1,922 |
| 2022 | 13 | 39 | None | $1,143 |
| 2021 | 11 | 20 | None | $611 |
| 2020 | 2 | 3 | None | $44 |
| 2019 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ucb | Bimzelx | $2,196 | 13 payments
|
| Abbvie | Skyrizi | $481 | 35 payments
|
| Organogenesis | Novachor | $265 | 5 payments
|
| LEO Pharma | Adbry | $228 | 17 payments
|
| Incyte | Opzelura | $70 | 3 payments
|
| Organon | Vtama | $69 | 8 payments
|
See all 101 published payments
| LEO Pharma | Meals · 2025-12-18 | Anzupgo | $17 |
| Ucb | Meals · 2025-12-11 | Bimzelx | $19 |
| Organon | Meals · 2025-12-09 | None | $13 |
| LEO Pharma | Meals · 2025-12-09 | Spevigo | $17 |
| LEO Pharma | Meals · 2025-12-03 | Anzupgo | $3 |
| Abbvie | Meals · 2025-12-02 | Skyrizi | $13 |
| Organon | Meals · 2025-12-02 | None | $9 |
| Abbvie | Meals · 2025-11-25 | Skyrizi | $26 |
| LEO Pharma | Meals · 2025-11-19 | Anzupgo | $3 |
| Abbvie | Meals · 2025-11-18 | Skyrizi | $17 |
| Organogenesis | Meals · 2025-11-07 | Nushield | $62 |
| Abbvie | Meals · 2025-11-06 | Skyrizi | $4 |
| Abbvie | Meals · 2025-11-06 | Skyrizi | $12 |
| LEO Pharma | Meals · 2025-11-05 | Anzupgo | $18 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-04 | Sotyktu | $22 |
| LEO Pharma | Meals · 2025-10-22 | Adbry | $4 |
| Pfizer | Meals · 2025-10-21 | Cibinqo | $22 |
| Lilly USA | Meals · 2025-10-15 | Ebglyss | $25 |
| Novartis Pharmaceuticals | Meals · 2025-10-07 | Cosentyx | $15 |
| Ucb | Meals · 2025-10-07 | Bimzelx | $13 |
| Abbvie | Meals · 2025-10-01 | Skyrizi | $7 |
| Galderma Laboratories L.P. | Meals · 2025-09-30 | Nemluvio | $20 |
| Abbvie | Meals · 2025-09-23 | Skyrizi | $17 |
| Abbvie | Meals · 2025-09-23 | Rinvoq | $9 |
| Abbvie | Meals · 2025-09-16 | Skyrizi | $28 |
| LEO Pharma | Meals · 2025-09-09 | Anzupgo | $25 |
| Pfizer | Meals · 2025-09-02 | Cibinqo | $19 |
| Janssen Biotech | Education · 2025-08-28 | Tremfya | $43 |
| Genzyme | Meals · 2025-08-28 | Dupixent | $33 |
| Abbvie | Meals · 2025-08-21 | Skyrizi | $11 |
| Abbvie | Meals · 2025-08-21 | Skyrizi | $2 |
| Abbvie | Meals · 2025-08-20 | Rinvoq | $12 |
| Amgen | Meals · 2025-08-19 | Otezla | $24 |
| Organogenesis | Meals · 2025-08-13 | Simplimax | $18 |
| Abbvie | Meals · 2025-08-12 | Skyrizi | $18 |
| Incyte | Meals · 2025-08-12 | Opzelura | $24 |
| Abbvie | Meals · 2025-08-07 | Skyrizi | $9 |
| Organon | Meals · 2025-08-07 | Vtama | $8 |
| LEO Pharma | Meals · 2025-08-05 | Adbry | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-29 | Sotyktu | $22 |
| Organon | Meals · 2025-07-23 | None | $6 |
| Abbvie | Meals · 2025-07-15 | Skyrizi | $11 |
| LEO Pharma | Meals · 2025-07-15 | Adbry | $24 |
| Abbvie | Meals · 2025-07-01 | Rinvoq | $34 |
| Incyte | Meals · 2025-07-01 | Opzelura | $22 |
| Abbvie | Meals · 2025-06-25 | Skyrizi | $9 |
| Ucb | Meals · 2025-06-25 | Bimzelx | $19 |
| Ucb | Meals · 2025-06-24 | Bimzelx | $25 |
| Abbvie | Meals · 2025-06-19 | Rinvoq | $12 |
| Arcutis Biotherapeutics | Meals · 2025-06-16 | Zoryve | $15 |
| Abbvie | Meals · 2025-06-10 | Skyrizi | $13 |
| Ucb | Consulting · 2025-06-10 | Bimzelx | $1,950 |
| LEO Pharma | Meals · 2025-06-10 | Adbry | $24 |
| Organogenesis | Meals · 2025-06-05 | Novachor | $140 |
| Abbvie | Meals · 2025-06-04 | Rinvoq | $16 |
| Regeneron Healthcare Solutions | Meals · 2025-06-03 | Dupixent | $33 |
| Ucb | Meals · 2025-06-02 | Bimzelx | $16 |
| Ucb | Meals · 2025-05-29 | Bimzelx | $87 |
| Genzyme | Meals · 2025-05-28 | Dupixent | $18 |
| Galderma Laboratories L.P. | Meals · 2025-05-23 | Nemluvio | $15 |
| Abbvie | Meals · 2025-05-21 | Skyrizi | $9 |
| Incyte | Meals · 2025-05-20 | Opzelura | $24 |
| Organogenesis | Meals · 2025-05-20 | Via Matrix | $11 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-13 | Sotyktu | $22 |
| Genzyme | Meals · 2025-05-07 | Dupixent | $15 |
| LEO Pharma | Meals · 2025-05-06 | Adbry | $24 |
| Abbvie | Meals · 2025-05-02 | Rinvoq | $21 |
| LEO Pharma | Meals · 2025-04-30 | Adbry | $4 |
| Abbvie | Meals · 2025-04-25 | Skyrizi | $29 |
| Abbvie | Meals · 2025-04-15 | Skyrizi | $21 |
| Ucb | Meals · 2025-04-15 | Bimzelx | $1 |
| Ucb | Meals · 2025-04-15 | Bimzelx | $15 |
| LEO Pharma | Meals · 2025-04-15 | Adbry | $3 |
| Abbvie | Meals · 2025-04-04 | Skyrizi | $5 |
| Abbvie | Meals · 2025-04-04 | Skyrizi | $13 |
| Ucb | Meals · 2025-03-26 | Bimzelx | $17 |
| Abbvie | Meals · 2025-03-18 | Skyrizi | $15 |
| LEO Pharma | Meals · 2025-03-17 | Adbry | $19 |
| Abbvie | Meals · 2025-03-11 | Skyrizi | $10 |
| Organon | Meals · 2025-03-05 | Vtama | $3 |
| Organon | Meals · 2025-03-05 | Vtama | $10 |
| LEO Pharma | Meals · 2025-03-05 | Adbry | $2 |
| Abbvie | Meals · 2025-02-27 | Skyrizi | $8 |
| Organon | Meals · 2025-02-27 | Vtama | $9 |
| Abbvie | Meals · 2025-02-20 | Skyrizi | $14 |
| LEO Pharma | Meals · 2025-02-17 | Adbry | $18 |
| Sun Pharmaceutical Industries | Meals · 2025-02-11 | Ilumya | $25 |
| Pfizer | Meals · 2025-02-06 | Cibinqo | $20 |
| Abbvie | Meals · 2025-02-05 | Skyrizi | $1 |
| Abbvie | Meals · 2025-02-05 | Skyrizi | $9 |
| Ucb | Meals · 2025-02-04 | Bimzelx | $17 |
| Abbvie | Meals · 2025-01-30 | Skyrizi | $13 |
| Regeneron Healthcare Solutions | Meals · 2025-01-28 | Dupixent | $24 |
| Amgen | Meals · 2025-01-23 | Otezla | $28 |
| Abbvie | Meals · 2025-01-21 | Rinvoq | $23 |
| Organogenesis | Meals · 2025-01-16 | Cygnus Dual | $34 |
| Ucb | Meals · 2025-01-15 | Bimzelx | $8 |
| Ucb | Meals · 2025-01-15 | Bimzelx | $9 |
| Organon | Meals · 2025-01-13 | Vtama | $11 |
| Abbvie | Meals · 2025-01-09 | Skyrizi | $10 |
| LEO Pharma | Meals · 2025-01-07 | Adbry | $3 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,410
| Abbvie | Rinvoq | $642 | 35 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $373 | 21 payments
|
| Dermavant Sciences | Vtama | $283 | 28 payments
|
| Ucb | Bimzelx | $277 | 22 payments
|
| Janssen Biotech | Tremfya | $196 | 7 payments
|
| LEO Pharma | Adbry | $105 | 5 payments
|
| Pfizer | Eucrisa | $100 | 6 payments
|
| Sun Pharmaceutical Industries | Ilumya | $85 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $76 | 3 payments
|
| Lilly USA | Taltz | $71 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $61 | 2 payments
|
| Amgen | Otezla | $44 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $33 | 2 payments
|
| Organon | Hadlima | $29 | 2 payments
|
| Incyte | Opzelura | $20 | 1 payment
|
| Galderma Laboratories L.P. | None | $13 | 1 payment
|
| Biofrontera | Ameluz | $2 | 1 payment
|
2023: $1,922
| E.R. Squibb & Sons L.L.C. | Sotyktu | $494 | 25 payments
|
| Genzyme | Dupixent | $250 | 6 payments
|
| AbbVie | Rinvoq | $231 | 11 payments
|
| Dermavant Sciences | Vtama | $205 | 5 payments
|
| Janssen Biotech | Tremfya | $158 | 5 payments
|
| Lilly USA | Taltz | $126 | 6 payments
|
| Novartis Pharmaceuticals | Cosentyx | $91 | 1 payment
|
| Pfizer | Eucrisa | $84 | 5 payments
|
| Sun Pharmaceutical Industries | Ilumya | $75 | 3 payments
|
| LEO Pharma | Adbry | $70 | 3 payments
|
| Biofrontera | Ameluz | $38 | 3 payments
|
| Mayne Pharma Commercial | None | $30 | 2 payments
|
| Regeneron Healthcare Solutions | Libtayo | $25 | 1 payment
|
| Galderma Laboratories L.P. | None | $23 | 1 payment
|
| Incyte | Opzelura | $22 | 1 payment
|
2022: $1,143
| Abbvie | Skyrizi | $303 | 17 payments
|
| LEO Pharma | Adbry | $142 | 3 payments
|
| Amgen | Otezla | $142 | 2 payments
|
| Janssen Biotech | Tremfya | $126 | 4 payments
|
| Incyte | Opzelura | $91 | 3 payments
|
| Lilly USA | None | $86 | 1 payment
|
| Genzyme | Dupixent | $65 | 1 payment
|
| Ucb | Cimzia | $49 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $44 | 2 payments
|
| Pfizer | Eucrisa | $33 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $30 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $20 | 1 payment
|
| Smith+Nephew | Pico | $12 | 1 payment
|
2021: $611
| Janssen Scientific Affairs | Tremfya | $125 | 1 payment
|
| Amgen | Otezla | $124 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $107 | 1 payment
|
| Janssen Biotech | Tremfya | $80 | 6 payments
|
| AbbVie | Skyrizi | $67 | 4 payments
|
| Genzyme | Dupixent | $25 | 1 payment
|
| Kyowa Kirin | Poteligeo | $23 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $20 | 1 payment
|
| Lilly USA | Taltz | $15 | 1 payment
|
| Helsinn Therapeutics (U.S.) | Valchlor | $13 | 1 payment
|
| Pfizer | Eucrisa | $13 | 1 payment
|
2020: $44
| Pfizer | Eucrisa | $26 | 2 payments
|
| Genzyme | Dupixent | $18 | 1 payment
|
2019: $125
| Celgene | Otezla | $125 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1093219339
- Licence
- GA 91215, GA 9942
- Trained
- Mercer University School of Medicine, 2018
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- Po Box 23329, New York, NY, 10087
- NPI first listed
- 2018-03-21
- NPI last updated
- 2026-03-27
- NPI record certified
- 2026-03-27
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1203 Town Park Ln, Evans, GA, 30809